MARINE ACTINOMYCETES AS A SUSTAINABLE REMEDY TO EMERGING DRUG RESISTANCE IN CLINICAL SCENARIO

Main Article Content

P. DEEPA MATHEW
K. SUKESH

Abstract

The paper deals with the use of marine actinomycetes as a sustainable remedy against emerging drug resistance. Actinomycetes are unique among prokaryotes due to their filamentous nature, differentiated life cycle and metabolic versatility. Successful and effective exploitation of actinomycetes relies upon the characterization of actinomycetes from unexplored habitats which in turn unravels the ecological and biotechnological perspectives of the organism.

Keywords:
Actinomycetes, drug resistance, remedial measure

Article Details

How to Cite
MATHEW, P. D., & SUKESH, K. (2021). MARINE ACTINOMYCETES AS A SUSTAINABLE REMEDY TO EMERGING DRUG RESISTANCE IN CLINICAL SCENARIO. Journal of Basic and Applied Research International, 27(2), 17-35. Retrieved from https://ikprress.org/index.php/JOBARI/article/view/6213
Section
Review Article

References

Khan SN, Khan AU. Breaking the spell: Combating multidrug-resistant ‘Superbugs’. Front. Microbiol. 2016;7:174.

Gajdács M. The Concept of an ideal antibiotic: Implications for Drug Design. Molecules. 2019;24:892.

Berdy J. Thoughts and facts about antibiotics: Where we are now and where we are heading. J. Antibiot. 2012;65:385–395.

Locey KJ, Lennon JT. Scaling laws predict global microbial diversity. Proc. Natl. Acad. Sci. USA. 2016;113:5970–5975.

Barka EA, Vatsa P, Sanchez L, Gaveau-Vaillant N, Jacquard C, Klenk HP, et al. Taxonomy, physiology, and natural products of Actinobacteria. Microbiol. Mol. Biol. Rev. 2016;80:1–43.

Subramani R, Aalbersberg W. Marine actinomycetes: an ongoing source of novel bioactive metabolites. Microbiol. Res. 2012; 167:571–580.

Dhakal D, Pokhrel AR, Shrestha B, Sohng JK. Marine rare actinobacteria: Isolation, characterization, and strategies for harnessing bioactive compounds. Front. Microbiol. 2017; 8:1106.

Azman AS, Othman I, Velu SS, Chan KG, Lee LH. Mangrove rare actinobacteria: Taxonomy, natural compound and discovery of bioactivity. Front. Microbiol. 2015;6:856.

Arul Jose P, Jha B. Intertidal marine sediment harbours Actinobacteria with promising bioactive and biosynthetic potential. Sci. Rep. 2017;7:10041.

Cumsille A, Undabarrena A, González V, Claverías F, Rojas C, Cámara B. Biodiversity of actinobacteria from the South Pacific and the assessment of Streptomyces chemical diversity with metabolic profiling. Mar. Drugs. 2017; 15:286.

Skropeta D, Wei L. Recent advances in deep-sea natural products. Nat. Prod. Rep. 2014;31:999–1025.

Das S, Lyla PS, Khan SA. Marine microbial diversity and ecology: Importance and future perspectives. Curr Sci. 2006;90:1325–35.

Jensen PR, Mincer TJ, Williams PG, Fenical W. Marine actinomycete diversity and natural product discovery. Antonie Van Leeuwenhoek. 2005;87:43–8.

Lam KS. Discovery of novel metabolites from marine actinomycetes. Curr Opin Microbiol 2006;9:245–51.

Ramesh S, Mathivanan N. Screening of marine actinomycetes isolated from the Bay of Bengal, India for antimicrobial activity and industrial enzymes. World J Microbiol Biotechnol. 2009;25:2103–11.

Chandramohan D, Ramu S, Natarajan R. Cellulolytic activity of marine streptomycetes. Curr Sci. 1972;41:245–6.

Pisano MA, Sommer MJ, Taras L. Bioactivity of chitinolytic actinomycetes of marine origin. Appl Microbiol Biotechnol. 1992;36: 553–5.

Goodfellow M, Haynes JA. Actinomycetes in marine sediments. In: Ortiz-ortiz L, Bojalil LF, Yokoleff V, editors. Biological, biochemical and biomedical aspects of actinomycetes. Orlando: Academic Press. 1984;453–72.

Berdy J. Bioactive microbial metabolites. J Antibiot (Tokyo). 2005;58:1–26.

Cuesta C, Garcia-de-la-Fuente R, Abad M, Fornes J. Isolation and identification of actinomycetes from a compost-amended soil with potential as biocontrol agents. J Environ Manage. 2012;95:S280–4.

Zhang J, Zhang L. Improvement of an isolation medium for actinomycetes. Mod Appl Sci. 2011;5:124–7.

Hayakawa M. Studies on the isolation and distribution of rare actinomycetes in soil. Actinomycetologica. 2008;22:12–9.

Hong K, Gao AH, Xie QY, Gao H, Zhuang L, Lin HP, et al. Actinomycetes for marine drug discovery isolated from mangrove soils and plants in China. Mar Drugs. 2009;7:24–44.

Bredholdt H, Galatenko OA, Engelhardt K, Fjaervik E, Terekhova LP, Zotchev SB. Rare actinomycete bacteria from the shallow water sediments of the Trodheim fjord, Norway: isolation, diversity and biological activity. Environ Microbiol. 2007;9:2756–64.

Maldonado LA, Fenical W, Jensen PR, Kauffman CA, Mincer TJ, Ward AC, et al. Salinispora arenicola gen. nov., sp. nov. and Salinispora tropica sp. nov., obligate marine actinomycetes belonging to the family Micromonosporaceae. Int J Syst Evol Microbiol. 2005a;55:1759–66.

Magarvey NA, Keller JM, Bernan V, Dworkin M, Sherman DH. Isolation and characterization of novel marine-derived actinomycete taxa rich in bioactive metabolites. Appl Environ Microbiol. 2004;70:7520–9.

Iwai K, Iwamoto S, Aisaka K, Suzuki M. Isolation of novel actinomycetes from spider materials. Actinomycetologica 2009;23:8–15.

Donadio S, Carrano L, Brandi L, Serina S, Soffientini A, Raimondi E, et al. Targets and assay for discovering novel antibacterial agents. J Biotechnol. 2002a;99:175–85.

Donadio S, Monciardini P, Alduina R, Mazza P, Chiocchini C, Cavaletti L, et al. Microbial technologies for the discovery of novel bioactive metabolites. J Biotechnol. 2002b;99:187–98.

Hozzein WN, Ali MIA, Rabie W. A new preferential medium for enumeration and isolation of desert actinomycetes. World J Microbiol Biotechnol. 2008;24:1547–52.

Mincer TJ, Fenical W, Jensen PR. Culture-dependent and culture-independent diversity within the obligate marine actinomycete genus Salinispora. Appl Environ Microbiol. 2005;71:7019–28.

Velho-Pereira S, Kamat N. Digital image analysis of actinomycetes colonies as a potential aid for rapid taxonomic identification. Nat Precedings; 2010.

Available:http://dx.doi.org/10.1038/npre.2010.4209.1

O’Donnell AG, Embley TM, Goodfellow M. Future of Bacterial Systematics. Handbook of New Bacterial Systematics. Academic Press, London; 1993.

Gajdács M, Spengler G, Urbán E. Identification and antimicrobial susceptibility testing of anaerobic bacteria: Rubik's Cube of Clinical Microbiology? Antibiotics (Basel). 2017;6:25.

Das M, Royer TV, Leff LG. Diversity of fungi, bacteria, and actinomycetes on leaves decomposing in a stream. Appl Environ Microbiol. 2007;73:756–67.

Sun W, Dai S, Jiang S, Wang G, Liu G, Wu H, et al. Culture-dependent and culture independent diversity of actinobacteria associated with the marine sponge Hymeniacidon perleve from the south China sea. Antonie Van Leeuwenhoek. 2010;98:65–75.

Bull AT, Stach JEM, Ward AC, Goodfellow M. Marine actinobacteria: Perspectives, challenges, future directions. Antonie Van Leeuwenhoek. 2005;87:65–79.

Stach JEM, Maldonado LA, Ward AC, Goodfellow M, Bull AT. New primers specific for taxa assigned to the class actinobacteria: Application to marine and terrestrial environments. Environ Microbiol. 2003;5:828–41.

Monciardini P, Sosio M, Cavaletti L, Chiocchini C, Donadio S. New PCR primers for the selective amplification of 16S rDNA from different groups of actinomycetes. FEMS Microbiol Ecol. 2002;42:419–29.

Wawrik B, Kerkhof L, Zylstra GJ, Kukor JJ. Identification of unique type II polyketide synthase genes in soil. Appl Environ Microbiol. 2005;71:2232–8.

Nimnoi P, Pongsilpb N, Lumyong S. Genetic diversity and community of endophytic actinomycetes within the roots of Aquilaria crassna Pierre ex Lec assessed by Actinomycetes-specific PCR and PCR-DGGE of 16S rRNA gene. Biochem Syst Ecol. 2010;38:595–601.

Fenical W, Jensen PR. Developing a new resource for drug discovery: marine actinomycetes bacteria. Nat Chem Biol. 2006;2:666–73.

Kennedy J, Flemer B, Jackson SA, Lejon DPH, Morrissey JP, O’Gara F, et al. Marine metagenomics: New tools for the study and exploitation of marine microbial metabolism. Mar Drugs. 2010;8:608–28.

Cho JY, Kwon HC, Williams PG, Jensen PR, Fenical W. Azamerone, a terpenoid phthalazinone from a marine derived bacterium related to the genus Streptomyces (Actinomycetales). Org Lett. 2006;8:2471–2474

Macherla VR, Liu J, Bellows C, Teisan S, Nicholson B, Lam KS, et al. Glaciapyrroles A, B and C pyrrolosesquiterpenes from a Streptomyces sp. isolated from an Alaskan marine sediment. J Nat Prod. 2005;68:780–783.

Wu SJ, Fotso S, Li F, Qin S, Laatsch H. Amorphane sesquiterpenes from a marine Streptomyces sp. J Nat Prod. 2007;70:304–306.

Hardt IH, Jensen PR, William F. Neomarinone and new cytotoxic marinone derivatives, produced by a marine fi lamentous bacterium (Actinomycetales). Science. 2000;41:2073–2076.

William PG, Asolkar RN, Kondratyuk T, Pezzuto JM, Jensen PR, Fenical W. Saliniketals A and B, bicyclic polyketides from the marine actinomycete Salinispora arenicola. J Nat Prod. 2007;70:83–88

Jensen PR, Williams PG, Oh DC, Zeigler L, Fenical W. Species-specifi c secondary metabolite production in marine actinomycetes of the genus Salinispora. Appl Environ Microbiol. 2007;73:1146–1152

Bister B, Bischoff D, Strobele M, Riedlinger J, Reicke A, Wolter F, et al. Abyssomicin C a polycyclic antibiotic from a marine Verrucosispora strain as an inhibitor of the p-aminobenzoic acid/tetrahydrofolate biosynthesis pathway. Chem Int Ed. 2004;43:2574–2576

Sujatha P, Bapi Raju KV, Ramana T. Studies on a new marine Streptomycete BT 408 producing polyketide antibiotic SBR-22 effective against methicillin resistant Staphylococcus aureus. Microbiol Res. 2005;160:119–126

Asolkar RN, Jensen PR, Kauffman CA, Fenical W. Daryamides A-C weakly cytotoxic polyketides from a marine derived actinomycete of the genus Streptomyces strain CNQ-085. J Nat Prod. 2006;69:1756–1759.

Cho JY, Kwon HC, Williams PG, Kauffman CA, Jensen PR, Fenical W. Actinofuranones A and B, polyketides from a marine derived bacterium related to the genus Streptomyces (Actinomycetales). J Nat Prod. 2006;69:425–428

Kanoh K, Matsuo Y, Adachi K, Imagawa H, Nishizawa M, Shizuri Y. Mechercharmycins A and B cytotoxic substances from marine derived Thermoactinomyces sp. YM 3-251. J Antibiot (Tokyo). 2005;58:289–292

Romero F, Espliego F, Perez Baz J, Garcia de Quesada T, Gravalos D, et al. Thiocoraline a new depsipeptide with antitumor activity produced by a marine Micromonospora. Taxonomy, fermentation isolation and biological activities. J Antibiot (Tokyo). 1997;50:734–737.

Renner MK, Shen YC, Cheng XC, Jensen PR, Frankmoelle W, Kauffman CA, et al. Cyclomarins A-C, new anti infl ammatory cyclic peptides produced by a marine bacterium (Streptomyces sp.). J Am Chem Soc. 1999;121:11273–11276.

Miller ED, Kauffman CA, Jensen PR, Fenical W. Piperazimycins cytotoxic hexadepsipeptides from a marine derived bacterium of the genus Streptomyces. J Org Chem. 2007;72:323–330.

Lee HS, Shin HJ, Jang KH, Kim TS, Oh KB and Shin J. Cyclic peptides of the Nocardamine class from a marine derived bacterium of the genus Streptomyces. J Nat Prod. 2005;68:623–625.

Matsuo Y, Kanoh K, Yamori T, Kasai H, Katsuta A, Adachi K, et al. Urukthapelstatin A, a novel cytotoxic substance from a marine derived Mechercharimyces asporophorigenes YM11-542. J Antibiot (Tokyo) 2007;60:251–255.

Moore BS, Trischman JA, Seng D, Kho D, Jensen PR, Fenical W. Salinamides, anti-infl amatory depsipeptides from a marine Streptomycete. J Org Chem. 1999;64:1145–1150.

Stritzke K, Schulz S, Laatsch H, Helmke E, Beil W. Novel caprolactones from a marine Streptomycete. J Nat Prod. 2004;67:395–401.

Li DH, Zhu TJ, Liu HB, Fanq YC, Gu OO, Zhu WM. Four butenolides are novel cytotoxic compounds isolated from the marine derived bacterium, Streptoverticillium luteoverticillatum 11014. Arch Pharm Res. 2006;29:624–626

Malet Cascon L, Romero F, Espliego Vazquez F, Gravalos D, Fernandez Puentes JL. IB00208, a new cytotoxic polycyclic xanthone produced by a marine derived Actinomadura. Isolation of the strain, taxonomy and biological activities. J Antibiot (Tokyo). 2003;56:219–225.

Hayakawa Y, Shirasaki S, Shiba S, Kawasaki T, Matsuo Y, Adachi K, et al. Piericidins C7 and C8, new cytotoxic antibiotics produced by a marine Streptomyces sp. J Antibiot (Tokyo). 2007;60:196–200.

Shiono Y, Shiono N, Seo S, Oka S, Yamazaki Y. Effects of polyphenolic anthrone derivatives resistomycin and hypericin on apoptois in human megakaryoblastic leukemia CMK-7cell2. Natuforsch. 2002;57: 923–929.

Adinaryan G, Venkateshan MR, Bpiraju VV, Sujatha P, Premkumar J, Ellaiah P, et al. Cytotoxic compounds from the marine actinobacterium. Bio Org Khim. 2006;32:328–334.

Kock I, Maskey RP, Biabani MAF, Helmke E, Laatsch H. 1-hydroxy-1-norresistomycin and resistofl avine methyl ether new antibiotics from marine derived Streptomycetes. J Antibiot (Tokyo). 2005;58:530–534

Gorajana AMV, Vinjamuri S, Kurada BV, Peela S, Jangam P, Poluri E, et al. Resistofl avine cytotoxic compound from a marine actinomycete, Streptomyces chibaensis AUBN(1)/7. Microbiol Res. 2006;29.

Itoh T, Kinoshita M, Aoki S, Kobayashi M. Komodoquinone A, a novel neuritogenic anthracycline from marine Streptomyces sp. KS3. J Nat Prod. 2003;66:1373–1377

Maskey RP, Helmke E, Laatsch H. Himalomycin A and B isolation and structure elucidation of new fridamycin type antibiotics from a marine Streptomyces isolate. J Antibiot (Tokyo). 2003;56:942–949.

Asolkar RN, Schroder D, Heckmann R, Lang S, Dobler IW, Laatsch H. Helquinoline, a new tetrahydroquinoline antibiotic from Janibacter limosus Hel1. J Antibiot (Tokyo). 2004;57:17–23.

Mercado IES, Davo AP, Jensen PR, Fenical W. Antibiotic terpenoid chloro-dihydroquinones from a new marine actinomycete. J Nat Prod. 2005;68:904–910.

Williams PG, Miller ED, Asolkar RN, Jensen PR, Fenical W. Arenicolides A-C, 26 membered ring macrolides from the marine actinomycete Salinispora arenicola. J Org Chem. 2007;72:5025–5034

Kwon HC, Kauffman CA, Jensen PR, Fenical W. Marinomycins A-D antitumor antibiotics of a new structure class from a marine actinomycete of the recently discovered genus Marinispora. J Am Chem Soc. 2006;128:1622–32

Liu R, Zhu T, Li D, Gu J, Xia W, Fang Y, et al. Two indolocarbazole alkaloids with apoptosis activity from a marine derived actinomycete Z2039–2. Arch Pharm Res. 2007;30:270–274

Schumacher RW, Talmage SC, Miller SA, Sarris KE, Davidson BS, Goldberg A. Isolation and structure determination of an antimicrobial ester from a marine sediment derived bacterium. J Nat Prod. 2003;66:1291–1293.

Li F, Maskey RP, Qin S, Sattler I, Fiebig HH, Maier A, et al. Chinikomycins A and B Isolation, structure elucidation and biological activity of novel antibiotics from a marine Streptomyces sp. isolate MO45. J Nat Prod. 2005;68:349–353.

Maskey RP, Helmke E, Kayser O, Fiebig HH, Maier A, Busche A, et al. Anticancer and antibacterial trioxacarcins with high anti-malaria activity from a marine Streptomycete and their absolute stereochemistry. J Antibiot (Tokyo). 2004;57:771–779.

Jeong SY, Shin HJ, Kim TS, Lee HS, Park SK, Kim HM. Streptokordin a new cytotoxic compound of the methylpyridine class from a marine derived Streptomyces sp. KORDI-3238. J Antibiot (Tokyo). 2006;59:234–240.

Feling RH, et al. Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinispora. Angew Chem Int End Engl. 2003;42:355–357.

Mitchell SS, Nicholson B, Teisan S, Lam KS, Potts BC. Aureoverticillactam, a novel 22-atom macrocyclic lactam from the marine actinomycete Streptomyces aureoverticillatus. J Nat Prod. 2004;67:1400–1402.

Imada C, Simidu U. Isolation and characterization of an alpha amylase inhibitor producing actinomycete from marine environment. Nippon Suisan Gakkaishi 1988;54:1839–1845.

Aoyama T, Kojima F, Imada C, Muraoka Y, Naqanawa H, Okami Y, et al. Pyrostatins A and B, new inhibitors of N-acetyl-beta-D-glucosamidase, produced by Streptomyces sp. SA3501. J Enzyme Inhib. 1995;8:223–232.

Aoyagi T, Hatsu M, Imada C, Naganawa H, Okami Y, Takeuchi T. Pyrizinostatin: A new inhibitor of pyroglutamyl peptidase. J Antibiot (Tokyo). 1992;45:1795–1796.

Peng F, Wang C, Xie Y, Jiang H, Chen L, Uribe P, et al. A new 20-membered macrolide produced by a marine-derived Micromonospora strain. Nat. Prod. Res. 2013;27:1366–1371.

Kim MC, Kwon OW, Park JS, Kim SY, Kwon HC, Nocapyrones HJ. 3,6-disubstituted α-pyrones from the marine actinomycete Nocardiopsis sp. KMF-001. Chem. Pharm. Bull. 2013;61:511–515.

Fu P, Kong F, Li X, Wang Y, Zhu W. Cyanogramide with a new spiro [indolinone-pyrroloimidazole] skeleton from Actinoalloteichus cyanogriseus. Org. Lett. 2014;16:3708–3711.

Kwon Y, Kim SH, Shin Y, Bae M, Kim BY, Lee SK, et al. A new benzofuran glycoside and indole alkaloids from a sponge-associated rare actinomycete, Amycolatopsis sp. Mar. Drugs. 2014;12:2326–2340.

Wagner M, Abdel-Mageed WM, Ebel R, Bull AT, Goodfellow M, Fiedler HP, et al. Dermacozines H-J isolated from a deep-sea strain of Dermacoccus abyssi from Mariana Trench sediments. J. Nat. Prod. 2014;77:416–420.

Liu D, Lin H, Proksch P, Tang X, Shao Z, Lin W. Microbacterins A and B, new peptaibols from the deep sea actinomycete Microbacterium sediminis sp. nov. YLB-01(T). Org. Lett. 2015;17:1220–1223.

Schulze CJ, Navarro G, Ebert D, De Risi J, Linington RG, Salinipostins AK. Long-chain bicyclic phosphotriesters as a potent and selective antimalarial chemotype. J. Org. Chem. 2015;80:1312–1320.

Kobayashi K, Fukuda T, Terahara T, Harunari E, Imada C, Tomoda H. Diketopiperazines, inhibitors of sterol O-acyltransferase, produced by a marine-derived Nocardiopsis sp. KM2-16. J. Antibiot. 2015;68:638–641.

Ferreira RJ, Kincses A, Gajdács M, Spengler G, Dos Santos DJVA, Molnár J, et al. Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers. J Nat Prod. 2018;81:2032-2040.

Wendt KU, Schulz GE. Isoprenoid biosynthesis: Manifold chemistry catalyzed by similar enzymes. Structure. 1998;6:127–133.

Hoeksema H, Smith CG. Novobiocin. Prog Ind Microbiol. 1961;3:91–139.

Das S, Lyla PS, Ajmal Khan S. Distribution and generic composition of culturable marine actinomycetes from the sediments of Indian continental slope of Bay of Bengal. Chin J Oceanol Limnol. 2008;26:166–77.

Martin JF, Demain AL. Control of antibiotic biosynthesis. Microbiol Rev. 1980; 44:230–51.

Sanchez S, Demain AL. Metabolic regulation of fermentation processes. Enzyme Microb Technol. 2002;31:895–906.

Sujatha P, Bapi Raju KVVSN, Ramana T. Studies on a new marine Streptomycete BT-408 producing polyketide antibiotic SBR-22 effective against methicillin resistant Staphylococcus aureus. Microbiol Res. 2005; 160:119–26.

Bode HB, Bethe B, Höfs R, Zeeck A. Big effects from small changes: possible ways to explore nature’s chemical diversity. Chem Biol Chem. 2002;3:619–27.

Fourati BFL, Fotso S, Ben Ameur-Mehdi R, Mellouli L, Laatsch H. Purification and structure elucidation of antifungal and antibacterial activities of newly isolated Streptomyces sp. strain US80. Res Microbiol. 2005;156:341–7.

Demain AL. Induction of microbial secondary metabolism. Int Microbiol. 1998;1:259–64.

Bibb MJ. Regulation of secondary metabolism in Streptomycetes. Curr Opin Microbiol. 2005;8:208–15.

Augustine SK, Bhavsar SP, Baserisalehi M, Kapadnis BP. Isolation and characterization of antifungal activity of an actinomycete of soil origin. Indian J Exp Biol. 2004;42:928–32.

Iwai Y, Omura S. Culture conditions for screening of new antibiotics. J Antibiot. 1982;35:123–41.

Wang YH, Yang B, Ren J, Dong ML, Liang D, Xu AL. Optimization of medium composition for the production of clavulanic acid by Streptomyces clavuligerus. Process Biochem. 2003;40:1116–66.

Gesheva V, Ivanova V, Gesheva R. Effects of nutrients on the production of AK-111-81 macrolide antibiotic by Streptomyces hygroscopicus. Microbiol Res. 2005;160:243–8.

Omura S, Tanaka Y. Macrolide antibiotics. In: Pape H, Rehn HJ, editors. Biotechnology, IV. Weinheim: VCH Verlagsgesellschaft. 1986; 360–91.

Tóth Á, Makai A, Jánvári L, Damjanova I, Gajdács M, Urbán E. Characterization of a rare blaVIM-4 metallo-β-lactamase-producing Serratia marcescens clinical isolate in Hungary. Heliyon. 2020;6: e04231.

Cheng JR, Fang A, Demain AL. Effect of amino acids on rapamycin biosynthesis in Streptomyces hygroscopicus. Appl Microbiol Biotechnol. 1995;43:1096–8.